• header_text.png
  • slider1.jpg
  • slider2.jpg
  • slider3.jpg

Dates: Jan 23-26, 2023
Organizers: Robert Thorne (Denali Therapeutics, University of Minnesota) & Reina Bendayan (University of Toronto)
Location: Beaver Run Conference Center, Breckenridge, Colorado, USA

We are excited to provide some LATE BREAKING NEWS about our upcoming KEYSTONE SYMPOSIUM on 'DRUG DELIVERY TO THE BRAIN: CHALLENGES AND PROGRESS', to be held January 23-26 at the Beaver Run Resort in Breckenridge, Colorado.

We currently have over 160 registrants and almost 70 poster abstracts for this first-of-its-kind meeting!
And there is STILL TIME TO REGISTER (we also have a few last remaining poster slots potentially: if interested, reach out soon - thorne [at] dnli [dot] com - along with an explanation of your interest and we will be happy to consider inclusion).

Consistent with the goals set for the conference, our meeting participants will include pretty much all of the key stakeholders in the CNS drug delivery space and a roughly equal number of academic and biopharma registrants. For those interested in a comprehensive snapshot of non-academic private sector research, the program is set to include scientific talks and poster presentations by companies such as AbbVie, Alkahest, Alnylam, Ascidian Therapeutics, Biogen, Cerebral Therapeutics, Denali Therapeutics, Eli Lilly, Genentech, Gubra, Ionis, Janssen, Lundbeck, Regeneron, Roche, and others. The potential for networking, collaboration, and the generation of new, innovative ideas at this meeting will be unprecedented!!

We will have workshop talks on imaging, big data, and QSP, a career networking session put on by the Keystone organization, and a concluding roundtable with an expert panel spanning the clinical space, neuro-oncology, lysosomal storage disorders, neurodegenerative diseases, cutting-edge drug delivery technology, biopharma, biotech, and the VC / startup world.

Our opening day keynote talk will be from Dr. Georg Terstappen (Cambrian Biopharma; see Terstappen et al. Nature Reviews Drug Discovery, 2021) and our closing day keynote talk will be from Prof. Viviana Gradinaru (California Institute of Technology; see Chen, Kumar, et al. [Gradinaru lab] Neuron, 2022). The program will feature an additional 34 short and long format talks from key opinion leaders, postdocs, and graduate students!
Our poster session (hard cap at 80) is right now set to run ALL 3 DAYS (with several hours devoted to it every evening) - this will be a clear highlight of the meeting and something that we will ask all of our attendees to focus upon. And we will have a number of poster prizes sponsored by the International Brain Barriers Society (ibbsoc.org) that will be awarded at the conclusion of the meeting!

Finally, for those of you that like winter sports such as skiing, there could not be a better venue for the event (picture below from www.breckenridge.com)! Please consider joining us for this inaugural Keystone Symposium on everything related to CNS drug delivery! And please do help us spread the word by forwarding to whoever might be interested! Hope to see you there!

Conference website: https://www.keystonesymposia.org/conferences/conference-listing/meeting?eventid=6789

Breckenridge Ski Resort Picture Jan 2022